SCICLONE PHARMACEUTICALS INC
SCICLONE PHARMACEUTICALS INC (SCLN) is a publicly traded company in the Unknown sector. Across all available filings, 25 corporate insiders have executed 542 transactions totaling $95.0M, demonstrating a bearish sentiment with -$86.5M in net insider flow. The most recent transaction on Oct 13, 2017 involved a transaction of 144,158 shares valued at $1.6M.
SCLN Insider Activity Summary
Who Is Buying SCLN Stock?
No significant insider buying has been recorded for SCLN in the recent period.
Who Is Selling SCLN Stock?
No significant insider selling has been recorded for SCLN in the recent period.
Is SCICLONE PHARMACEUTICALS INC Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for SCLN is bearish with an Insider Alignment Score of 4/100 and a net flow of -$86.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
SCLN Frequently Asked Questions
Understanding SCLN Insider Activity
Insider trading at SCICLONE PHARMACEUTICALS INC (SCLN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 25 insiders are actively trading SCLN stock, having executed 542 transactions in the past 90 days. The most active insider is Paolo Cavazza (Executive), who has made 50 transactions totaling $40.5M.
Related Tools
Track SCICLONE PHARMACEUTICALS INC Insider Activity
Get notified when executives and directors at SCLN file new Form 4 transactions